Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
J Surg Oncol. 2014 Apr;109(5):472-7. doi: 10.1002/jso.23514. Epub 2013 Dec 2.
To determine the role of surgery in complete responders on FDG-PET after CRT and the prognostic significance of metabolic response in locally advanced esophageal squamous cell carcinoma.
We retrospectively reviewed 154 patients with locally advanced esophageal cancer with increased uptake on FDG-PET. Eighty-one patients received definitive CRT and 73 received trimodality therapy. We defined metabolic complete remission (PET-CR) when FDG uptake of the primary tumor and lymph nodes were decreased and was indistinguishable from surrounding normal tissue. Oncologic outcomes were compared between trimodality group, definitive CRT group, and PET-CR subgroup of definitive CRT.
Thirty-one (38.3%) of the definitive CRT patients and 39 (53.4%) of the trimodality therapy patients achieved PET-CR after CRT. The 2-year OS of the trimodality group was higher than that of the definitive CRT group, but equivalent to that of the PET-CR subgroup of definitive CRT. The 2-year LRFS and DFS of the trimodality group were higher than that of the PET-CR subgroup or the entire of definitive CRT group.
The addition of surgery showed higher DFS and LRFS rates than those of the PET-CR subgroup of definitive CRT. Despite achieving PET-CR, surgery still seems to improve local tumor control.
明确经放化疗(CRT)后氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)完全缓解者手术的作用,以及局部晚期食管鳞癌代谢反应的预后意义。
我们回顾性分析了 154 例 FDG-PET 摄取增加的局部晚期食管癌患者。81 例患者接受根治性 CRT,73 例患者接受三联疗法。我们将原发肿瘤和淋巴结的 FDG 摄取减少且与周围正常组织无法区分的情况定义为代谢完全缓解(PET-CR)。比较三联疗法组、根治性 CRT 组和根治性 CRT 的 PET-CR 亚组的肿瘤学结局。
根治性 CRT 组 31 例(38.3%)和三联疗法组 39 例(53.4%)患者在 CRT 后达到 PET-CR。三联疗法组的 2 年总生存期(OS)高于根治性 CRT 组,但与根治性 CRT 的 PET-CR 亚组相当。三联疗法组的 2 年无局部区域复发生存率(LRFS)和无病生存率(DFS)高于 PET-CR 亚组或整个根治性 CRT 组。
与根治性 CRT 的 PET-CR 亚组相比,手术的加入提高了 DFS 和 LRFS 率。尽管达到了 PET-CR,但手术似乎仍能改善局部肿瘤控制。